NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01356511,High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP),https://clinicaltrials.gov/study/NCT01356511,,COMPLETED,The project was undertaking by Qilu Hospital of Shandong University and other 11 well-known hospitals in China. In order to report the efficacy and safety of high-dose dexamethasone compared to conventional dose prednisone for the first-line treatment of adults with primary immune thrombocytopenia(ITP).,NO,"Purpura, Thrombocytopenic, Idiopathic",DRUG: Prednisone|DRUG: Dexamethasone,"Proposed criteria for assessing response to ITP treatments, 1. Complete response (CR)： A platelet count ≥ 100 \* 10\^9/L measured on two occasions \> 7 days apart and the absence of bleeding.
2. Response (R)： A platelet count ≥ 30 \* 10\^9/L and a greater than two fold increase in platelet count from baseline measured on two occasions \> 7 days apart and the absence of bleeding.
3. No response (NR)： A platelet count \< 30 \* 10\^9/L or a less than two fold increase in platelet count from baseline or the presence of bleeding. Platelet count must be measured on two occasions more than a day apart., The time frame is up to 28 days per subject",,,Shandong University,"Chinese Academy of Medical Sciences|Peking Union Medical College Hospital|Ruijin Hospital|Wuhan Union Hospital, China|Tongji Hospital|Shandong University of Traditional Chinese Medicine|Anhui Provincial Hospital|Zhejiang Provincial Hospital of TCM|Second Hospital of Shanxi Medical University|People's Hospital of Xinjiang Uygur Autonomous Region|Shenzhen Second People's Hospital",ALL,"ADULT, OLDER_ADULT",PHASE4,261,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,ITP-002,2010-09,2014-05,2015-03,2011-05-19,,2016-04-20,"Qilu Hospital, Shandong University, Jinan, Shandong, China",
